| Application: | Internal Medicine |
|---|---|
| Usage Mode: | For external use |
| Suitable for: | Elderly, Children, Adult |
| State: | Solid |
| Shape: | Oral Liquid |
| Type: | Organic Chemicals |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier | Product name | Cefuroxime Sodium for Injection |
| Specificaton | 0.75g 1.5g |
| Certification | GMP ISO9001 ISO14001 |
| Standard | BP/CP |
| fuction | It is suitable for moderate and severe infection caused by pathogenic bacteria producing or not producing lactamase, lower respiratory tract infection, pneumonia, acute attack of chronic bronchitis, acute bronchitis, lung abscess and other lung infections; urinary system infection, acute glomerulonephritis, acute attack of chronic glomerulonephritis, complex urinary tract infection, abdominal infection, peritonitis, cholecystitis, bile duct Inflammation and other intra-abdominal infections, pelvic infections, pelvic inflammation and other infections. Sepsis, meningitis, skin and soft tissue infections. |
| taboo | Allergic to cefuroxime or other cephalosporins.. |
| Announcements | Cefuroxime is the second generation of broad-spectrum semi synthetic cephalosporins. Cefuroxime has strong antibacterial activity against almost all strains sensitive to cefotaxime and cefotaxime, and is effective against a wide range of gram-negative bacilli, including Enterobacter and indole positive proteus. The clinical and bacteriological effective rate of cefuroxime in the treatment of respiratory tract, five sense organs, bone, soft tissue infection, meningitis and simple urinary tract infection was 70% - 100%, and the prevention of postoperative infection was also satisfactory. Cefuroxime is very effective in the treatment of acute gonorrhea and urinary tract infection caused by Neisseria gonorrhoeae. 169 cases of gonorrhea were treated by intramuscular injection of cefuroxime at a single dose of 1.5g. The blister disappeared in 160 cases within 1-5 days after intramuscular injection. The cure rate was 97.7%. The short-term and long-term bacteriological cure rates of cefuroxime were 55% and 48% |
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}